PCSS Exchange Session 6 – Implement and Sustain, Part 2
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior Cost: No fee Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, social workers, clinical administrators and healthcare teams. Credit Designations Available: AMA PRA Category 1 […]
PCSS Exchange Session 6 – Implement and Sustain, Part 2
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.
PCSS Exchange Session 5 – Implement and Sustain, Part 1
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.
PCSS Exchange Session 4 – Prepare, Part 2
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.
PCSS Exchange Session 3 – Prepare, Part 1
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.
PCSS Exchange Session 2 – Explore, Part 2
PCSS Exchange is a six-session online course focused on the implementation of prescribing medications for treating opioid use disorder (MOUD) in a variety of healthcare settings. The course content is built around the EPIS (Explore, Prepare, Implement, Sustain) Framework of implementation.
PCSS Exchange Session 6 – Implement and Sustain, Part 2
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior Cost: No fee Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, clinical administrators and healthcare teams. Credit Designations Available: AMA PRA […]
PCSS Exchange Session 5 – Implement and Sustain, Part 1
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior Cost: No fee Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, clinical administrators and healthcare teams. Credit Designations Available: AMA PRA […]
PCSS Exchange Session 4 – Prepare, Part 2
Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior Cost: No fee Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, clinical administrators and healthcare teams. Credit Designations Available: AMA PRA […]
PCSS Exchange Session 6 – Implement and Sustain, Part 2
Once we’ve successfully managed the organizational and clinical steps to initiate treatment for patients with OUD, we need to consider how to best sustain this new service and ensure continued access to high-quality care for our most challenging patients. This session will review long-term staffing structure and needs as buprenorphine (or other pharmacotherapies) become part of the treatment landscape in the community. The session will also review the challenges in delivering buprenorphine treatment to a range of patient populations, including those with comorbid mental health and/or physical health conditions, pregnant patients, those with co-occurring pain, and poor responders.